Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson’s disease

References

• Ikeda K, Nakamura Y, Kiyozuka T, Aoyagi J, Hirayama T, Nagata R, et al. Serological profiles of urata, paraoxonase-1, ferritin and lipid in Parkinson’s diseases changes linked to diseases progression. Neurodegener Dis. 2011;8(4):252–258.
   PubMed Web of Science ®Google Scholar
• Yasuda T, Nakata Y, Mochizuki H. α-Synuclein and neuronal cell death. Mol Neurobiol. 2013;47(2):466–483.
   PubMed Web of Science ®Google Scholar
• Grammas P, Martinez J, Miller B. Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases. Expert Rev Mol Med. 2011;13:e19.
   PubMed Web of Science ®Google Scholar
• Li N, Worthmann H, Deb M, Chen S, Weissenborn K. Nitric oxide (NO) and asymmetric dimethylarginine (ADMA): their pathophysiological role and involvement in intracerebral hemorrhage. Neurol Res. 2011;33(5):541–548.
   PubMed Web of Science ®Google Scholar
• Mitkovski M, Padovan-Neto FE, Raisman-Vozari R, Ginestet L, da-Silva CA, Del-Bel EA. Investigations into potential extrasynaptic communication between the dopaminergic and nitrergic systems. Front Physiol. 2012;3:372.
   PubMed Web of Science ®Google Scholar
• Doherty GH. Nitric oxide in neurodegeneration: potential benefits of non-steroidal anti-inflammatories. Neurosci Bull. 2011;27(6):366–382.
   PubMed Web of Science ®Google Scholar
• Dolgo-Saburov VB, Daqaev SG, Kubarskaya LG, Solovjeva NE. The role of the nitric oxide generation system in neuroleptic-induced Parkinsonism. Dokl Biol Sci. 2012;444:144.
   PubMedGoogle Scholar
• Hsu CP, Lin SJ, Chung MY, Lu TM. Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failure. Atherosclerosis. 2012;225(2):504–510.
   PubMed Web of Science ®Google Scholar
• Chedraui P, Solis EJ, Bocci G, Gopal S, Russo E, Escobar GS, et al. Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia. J Matern Fetal Neonatal Med. 2013;26(3):226–232.
   PubMed Web of Science ®Google Scholar
• Aldamiz-Echevarrıa L, Andrade F. Asymmetric dimethylarginine, endothelial dysfunction and renal disease. Int J Mol Sci. 2012;13(9):11288–11311.
   PubMed Web of Science ®Google Scholar
• Scott JA, North ML, Rafii M, Huang H, Pencharz P, Subbarao P, et al. Asymmetric dimethylarginine is increased in asthma. Am J Respir Crit Care Med. 2011;184(7):779–785.
   PubMed Web of Science ®Google Scholar
• Uzar E, Evliyaoglu O, Toprak G, Acar A, Yucel Y, Calisir T, et al. Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine. J Headache Pain. 2011;12(2):239–243.
   PubMed Web of Science ®Google Scholar
• Asif M, Soiza RL, McEvoy M, Mangoni AA. Asymmetric dimethylarginine: a possible link between vascular disease and dementia. Curr Alzheimer Res. 2013;10(4):347–356.
   PubMed Web of Science ®Google Scholar
• Miller AL. The methionine-homocysteine cycle and its effects on cognitive diseases. Altern Med Rev. 2003;8(1):7–19.
   PubMedGoogle Scholar
• Sharma M, Tiwari M, Tiwari RK. Hyperhomocysteinemia: impact on neurodegenerative diseases. Basic Clin Pharmacol Toxicol. 2015;117(5):287–296.
   PubMed Web of Science ®Google Scholar
• Daniel SE, Lees AJ. Parkinson’s Disease Society Brain Bank, London: overview and research. J Neural Transm. 1993;39:165–172.
   Google Scholar
• Hubert JD, Seahorn TL, Klei TR, Hosgood G, Moore RM. Temporal effects of freezing on plasma nitric oxide concentrations in ponies. Can J Vet Res. 2003;67(1):72–74.
   PubMed Web of Science ®Google Scholar
• Farrell AJ, Blake DR, Palmer RM, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis. 1992;51:1219–1222.
   PubMed Web of Science ®Google Scholar
• Bialecka M, Robowski P, Honczarenko K, Roszmann A, Slawek J. Genetic and environmental factors for hyperhomocysteinaemia and its clinical implications in Parkinson’s disease. Neurol Neurochir Pol. 2009;43(3):272–285.
   PubMed Web of Science ®Google Scholar
• Avendano-Cantos EM, Celis-Sanchez J, Mesa-Varona D, Galvez-Martinez J, Lopez-Arroguıa E, Gonzalez Del Valle F. Corneal toxicity due to amantadine. Arch Soc Esp Oftalmol. 2012;87(9):290–293.
   PubMedGoogle Scholar
• Kwiecien S, Ptak-Belowska A, Krzysiek-Maczka G, Targosz A, Jasnos K, Magierowski M, et al. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, interacts with gastric oxidative metabolism and enhances stress-induced gastric lesions. J Physiol Pharmacol. 2012;63(5):515–524.
   PubMed Web of Science ®Google Scholar
• Xiao HB, Liu ZK, Lu XY, Deng CN, Luo ZF. Icariin regulates PRMT/ADMA/DDAH pathway to improve endothelial function. Pharmacol Rep. 2015;67(6):1147–1154.
   PubMed Web of Science ®Google Scholar
• Lakowski TM, Frankel A. Kinetic analysis of human protein arginine N-methyltransferase 2: formation of monomethyl- and asymmetric dimethyl-arginine residues on histone H4. Biochem J. 2009;421(2):253–261.
   PubMed Web of Science ®Google Scholar
• Monti LD, Galluccio E, Fontana B, Spadoni S, Comola M, Marrocco Trischitta MM, et al. Pharmacogenetic influence of eNOS gene variant on endothelial and glucose metabolism responses to L-arginine supplementation: Post hoc analysis of the L-arginine trial. Metabolism. 2015;64(11):1582–1591.
   PubMed Web of Science ®Google Scholar
• Pushpakumar S, Kundu S, Sen U. Endothelial dysfunction: the link between homocysteine and hydrogen sulfide. Curr Med Chem. 2014;21(32):3662–3672.
   PubMed Web of Science ®Google Scholar
• Chen S, Wu P, Zhou L, Shen Y, Li Y, Song H. Relationship between increase of serum homocysteine caused by smoking and oxidative damage in elderly patients with cardiovascular disease. Int J Clin Exp Med. 2015;8(3):4446–4454.
   PubMed Web of Science ®Google Scholar
• Lai WK, Kan MY. Homocysteine-Induced Endothelial Dysfunction. Ann Nutr Metab. 2015;67(1):1–12.
   PubMed Web of Science ®Google Scholar
• Yang RX, Huang SY, Yan FF, Lu XT, Xing YF, Liu Y, et al. Danshensu protects vascular endothelia in a rat model of hyperhomocysteinemia. Acta Pharmacol Sin. 2010;31(10):1395–1400.
   PubMed Web of Science ®Google Scholar
• Mansoor MA, Seljeflot I, Arnesen H, Knudsen A, Bates CJ, Mishra G, et al. Endothelial cell adhesion molecules in healthy adults during acute hyperhomocysteinemia and mild hypertriglyceridemia. Clin Biochem. 2004;37(5):408–414.
   PubMed Web of Science ®Google Scholar
• Chambers JC, McGregor A, Jean-Marie J, Kooner JS. Acute yperhomocysteinemia and endothelial dysfunction. Lancet. 1998;351(9095):36–37.
   PubMed Web of Science ®Google Scholar
• Woo KS, Sanderson JE, Sun YY, Chook P, Cheung AS, Chan LT, et al. Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction in human. Circulation. 2000;28(12):116.
   Google Scholar
• Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocysteinemia is associated with impaired endothelium –dependent vasodilation in humans. Circulation. 1997;95(5):1119–1121.
   PubMed Web of Science ®Google Scholar
• de Valk-de Roo GW, Stehouwer CD, Lambert J, Schalkwijk CG, van der Mooren MJ, Kluft C, et al. Plasma homocysteine is weakly correlated with plasma endothelin and von Willebrand factor but not with endothelium-dependent vasodilatation in healthy postmenopausal women. Clin Chem. 1999;45(1):1200–1205.
   PubMed Web of Science ®Google Scholar
• Bostantjopoulou S, Katsarou Z, Frangia T, Hatzizisi O, Papazisis K, Kyriazis G, et al. Endothelial function markers in parkinsonian patients with hyperhomocysteinemia. J Clin Neurosci. 2005;12(6):669–672.
   PubMed Web of Science ®Google Scholar